Top 200 Drugs Study

Flashcards, Quiz & Reference

Veröffentlicht von: Polemics Applications

Beschreibung

Top 200 Drugs - Flashcards, Quiz & Reference is a comprehensive study companion for healthcare professionals, students, and anyone looking to master the most commonly prescribed medications.
Key Features:
- Flash Card Study with multiple question types and customizable deck sizes
- Dictionary Mode with searchable drug database and Wikipedia integration
- Quiz Mode for testing knowledge with multiple choice questions
- Guided Learning to create custom study sets
- Direct links to Wikipedia articles for in-depth drug information
Study Categories:
- Brand Names and Generic Equivalents
- Primary Uses and Indications
- Drug Categories and Classifications
- Mechanisms of Action
- Side Effects and Patient Counseling
- DEA Schedules and Important Warnings
Perfect For:
- Pharmacy Technicians and Students
- Nursing Students and Professionals
- Medical Professionals
- Healthcare Students
- Board Exam Preparation
Flash Card Study adapts to your learning needs with multiple question types. Choose custom study sessions with 5, 10, 15, or 20 cards, or work through the entire deck. Each card can test your knowledge of brand names, primary uses, mechanisms of action, and more.
Dictionary Mode provides a complete reference list of all 200 drugs with quick search functionality. Each drug entry includes comprehensive information and links directly to Wikipedia articles for deeper learning and detailed pharmaceutical information.
Quiz Mode tests your knowledge through interactive multiple-choice questions with randomized answers. Review missed questions to strengthen weak areas and track your progress with immediate feedback. Our quiz system helps you build confidence through active recall.
Guided Learning lets you create custom study sets focusing on specific medications. Select five or more drugs to study using either flash cards or quiz mode - perfect for mastering challenging medications or preparing for exams.
Features a clean, straightforward interface designed to maximize study efficiency without unnecessary distractions. Whether you're preparing for exams or keeping your knowledge current, this app provides the flexibility and comprehensive coverage you need for success in healthcare.
Ausblenden Mehr anzeigen...

Screenshots

Top 200 Drugs Study Häufige Fragen

  • Ist Top 200 Drugs Study kostenlos?

    Ja, Top 200 Drugs Study ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist Top 200 Drugs Study seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Top 200 Drugs Study?

    Top 200 Drugs Study ist kostenlos.

  • Wie hoch ist der Umsatz von Top 200 Drugs Study?

    Um geschätzte Einnahmen der Top 200 Drugs Study-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Kasachstan noch nicht bewertet.
Bewertungsverlauf

Top 200 Drugs Study Bewertungen

Keine Bewertungen in Kasachstan
Die App hat noch keine Bewertungen in Kasachstan.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Bezahlt
177

Top 200 Drugs Study Installationen

Letzte 30 Tage

Top 200 Drugs Study Umsatz

Letzte 30 Tage

Top 200 Drugs Study Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Top 200 Drugs Study mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.